Trust Company of Vermont’s West Pharmaceutical WST Stock Holding History

Trust Company of Vermont’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$68.8K	Hold	250	–	–	﹤0.01%	514
2025 Q3	$65.6K	Hold	250	–	–	﹤0.01%	519
2025 Q2	$54.7K	Sell	250 -50	-17%	-$10.7K	﹤0.01%	535
2025 Q1	$67.2K	Hold	300	–	–	﹤0.01%	477
2024 Q4	$98.3K	Hold	300	–	–	﹤0.01%	428
2024 Q3	$90K	Buy	+300	New	+$91.9K	﹤0.01%	426
2017 Q3	–	Sell	-54	Closed	-$5K	–	989
2017 Q2	$5K	Buy	+54	New	+$4.97K	﹤0.01%	825
2016 Q3	–	Sell	-37	Closed	-$3K	–	872
2016 Q2	$3K	Buy	+37	New	+$2.69K	﹤0.01%	785
2016 Q1	–	Sell	-42	Closed	-$3K	–	784
2015 Q4	$3K	Buy	+42	New	+$2.53K	﹤0.01%	726

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Trust Company of Vermont's WST Position: Q4 2025 in Review

Trust Company of Vermont held its West Pharmaceutical (WST) position steady in Q4 2025 at 250 shares worth $68.8K. The position accounts for ﹤0.01% of the portfolio, ranked #514.

Trust Company of Vermont first reported a position in WST in Q4 2015 and has held it in 9 quarters since. The position peaked at $98.3K in Q4 2024. 803 funds tracked by Wall St. Rank hold WST as of Q4 2025.

Trust Company of Vermont held 250 shares of West Pharmaceutical worth $68.8K as of Q4 2025.
Trust Company of Vermont left its West Pharmaceutical share count unchanged in Q4 2025.
West Pharmaceutical made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #514 holding.
Trust Company of Vermont first reported a position in West Pharmaceutical in Q4 2015 and has held it in 9 quarters since.
Trust Company of Vermont's West Pharmaceutical position peaked at $98.3K in Q4 2024.
803 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.